Literature DB >> 24288588

Nitric oxide-flux dependent bacterial adhesion and viability at fibrinogen-coated surfaces.

Scott P Nichols1, Mark H Schoenfisch.   

Abstract

Nitric oxide (NO) is an endogenous antibacterial agent produced by immune cells in response to pathogens. Herein, the NO fluxes necessary to reduce bacterial adhesion of different bacteria (S. aureus, methicillin-resistant S. aureus, S. epidermidis, E. faecalis, E. coli, and P. aeruginosa) were investigated to ascertain the sensitivity of these bacteria to NO. S-nitrosothiol NO donor-modified xerogels were selected as a model NO-release surface due to their extended NO-release kinetics relative to other NO donor systems. The xerogels were coated with poly(vinyl chloride) (PVC) to achieve consistent surface energy between NO-releasing and control substrates. Fibrinogen was pre-adsorbed to these materials to more accurately mimic conditions encountered in blood and promote bacteria adhesion. Nitric oxide fluxes ranging from 20-50 pmol cm-2 s-1 universally inhibited the bacterial adhesion by >80% for each strain studied. Maximum bacteria killing activity (reduced viability by 85-98%) was observed at the greatest NO payload (1700 nmol cm-2).

Entities:  

Year:  2013        PMID: 24288588      PMCID: PMC3839865          DOI: 10.1039/C3BM60130G

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  38 in total

1.  Biofilm formation by five species of Candida on three clinical materials.

Authors:  D Estivill; A Arias; A Torres-Lana; A J Carrillo-Muñoz; M P Arévalo
Journal:  J Microbiol Methods       Date:  2011-06-12       Impact factor: 2.363

Review 2.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.

Authors:  F C Fang
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 3.  Nitric oxide release: part I. Macromolecular scaffolds.

Authors:  Daniel A Riccio; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2012-02-24       Impact factor: 54.564

Review 4.  Nitric oxide release: part II. Therapeutic applications.

Authors:  Alexis W Carpenter; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2012-02-24       Impact factor: 54.564

Review 5.  Reducing implant-related infections: active release strategies.

Authors:  Evan M Hetrick; Mark H Schoenfisch
Journal:  Chem Soc Rev       Date:  2006-05-05       Impact factor: 54.564

6.  A fibrinogen-binding protein of Staphylococcus epidermidis.

Authors:  M Nilsson; L Frykberg; J I Flock; L Pei; M Lindberg; B Guss
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant pathogens.

Authors:  Benjamin J Privett; Susan M Deupree; Christopher J Backlund; Kavitha S Rao; C Bryce Johnson; Peter N Coneski; Mark H Schoenfisch
Journal:  Mol Pharm       Date:  2010-11-11       Impact factor: 4.939

8.  A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity.

Authors:  Anthony R Richardson; Stephen J Libby; Ferric C Fang
Journal:  Science       Date:  2008-03-21       Impact factor: 47.728

Review 9.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.

Authors:  D A Wink; J B Mitchell
Journal:  Free Radic Biol Med       Date:  1998-09       Impact factor: 7.376

Review 10.  The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver.

Authors:  Douglas Roberto Monteiro; Luiz Fernando Gorup; Aline Satie Takamiya; Adhemar Colla Ruvollo-Filho; Emerson Rodrigues de Camargo; Debora Barros Barbosa
Journal:  Int J Antimicrob Agents       Date:  2009-03-31       Impact factor: 5.283

View more
  3 in total

1.  Nitric oxide releasing halloysite nanotubes for biomedical applications.

Authors:  Sama Ghalei; Sean Hopkins; Megan Douglass; Mark Garren; Arnab Mondal; Hitesh Handa
Journal:  J Colloid Interface Sci       Date:  2021-01-21       Impact factor: 8.128

2.  Electrochemically modulated nitric oxide (NO) releasing biomedical devices via copper(II)-Tri(2-pyridylmethyl)amine mediated reduction of nitrite.

Authors:  Hang Ren; Jianfeng Wu; Chuanwu Xi; Nicolai Lehnert; Terry Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  ACS Appl Mater Interfaces       Date:  2014-03-14       Impact factor: 9.229

3.  Interplay between enterohaemorrhagic Escherichia coli and nitric oxide during the infectious process.

Authors:  Ilham Naïli; Marion Gardette; Annie Garrivier; Julien Daniel; Mickaël Desvaux; Mariagrazia Pizza; Alain Gobert; Thierry Marchal; Estelle Loukiadis; Grégory Jubelin
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.